Population Health, Equity & Outcomes
December 2015
Volume: 3
Issue: 4
September 2015
Volume: 3
Issue: 3
June 2015
Volume: 3
Issue: 2
March 2015
Volume: 3
Issue: 1
Advertisement
Advertisement
Trending on AJMC
1
5 FAQs: Ebola Outbreaks and the Challenge of Public Trust
2
MRD-Guided CLL Treatment Duration: Personalization or Malpractice?
3
Tec-Dara Demonstrates Superior 3-Year PFS vs Standard Therapy in Functional High-Risk Myeloma: Rahul Banerjee, MD
4
Blinatumomab Improves Outcomes, Toxicity in High-Risk Pediatric ALL: Martin Schrappe, MD, PhD
5